Shanghai Rightongene Biotechnology Co.Ltd(688217) : list of incentive objects first granted by restricted stock incentive plan in 2022

Shanghai Rightongene Biotechnology Co.Ltd(688217)

List of incentive objects first granted under the restricted stock incentive plan in 2022

1、 Distribution of restricted stock incentive plan

Proportion of granted restrictions to granted restrictions to the total number of job-related shares of this incentive plan name nationality proportion of total number of shares on the day of announcement (10000 shares)

1、 Senior managers and core technicians

Li Yan, chief financial officer and board of directors of China 1.8 1.38% 0.03%

secretary

Zhang Chengli, deputy general manager of China 1.5 1.15% 0.03%

Xie Liqun Chinese core technical personnel 1.5 1.15% 0.03%

Yizhe Australian core technicians 1.5 1.15% 0.03%

Liu II. Key technical and business personnel

Technical and business backbone personnel (189 persons) 97.7 75.15% 1.76%

Total number of restricted shares granted for the first time (1.87%)

3、 Reserved part 26 20.00% 0.47%

Total 130100.00% 2.34%

Note: 1. The shares of the company granted by any of the above incentive objects through all the equity incentive plans within the validity period do not exceed 1% of the total share capital of the company. The total number of underlying shares involved in the incentive plan within the whole validity period of the company shall not exceed 20% of the total share capital of the company when the equity incentive plan is submitted to the general meeting of shareholders for deliberation.

2. The incentive objects of this incentive plan do not include independent directors, supervisors, shareholders who individually or jointly hold more than 5% of the shares of the listed company, actual controllers of the listed company and their spouses, parents and children.

3. The incentive objects of the reserved part shall be determined within 12 months after the incentive plan is considered and approved by the general meeting of shareholders. After the proposal of the board of directors, the explicit opinions of the independent directors and the board of supervisors, the professional opinions of lawyers and the legal opinions are issued, the company shall timely and accurately disclose the relevant information of the incentive objects on the designated website as required.

4. If there is any difference in the mantissa between the sum of some total numbers and each detailed number in the above table, it is caused by rounding.

Shanghai Rightongene Biotechnology Co.Ltd(688217) board of directors

March 11, 2022

- Advertisment -